Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Ovarian Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urogenital Neoplasms 1Papillomavirus Infections 1Melanoma 1Lung Neoplasms 1Endometrial Neoplasms 1Diarrhea 1Colitis 1Carcinoma in Situ 1Breast Neoplasms 1

Interventions

fludarabine 4aldesleukin 4Cyclophosphamide 4pembrolizumab 3niraparib 2Riluzole 2olaparib 1motexafin gadolinium 1lenvatinib 1anlotinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Specimen Handling 1Remote Patient Monitoring 1Pregnancy Tests 1Pemetrexed 1Paclitaxel 1Ocoxin 1Loperamide 1Imagery, Psychotherapy 1Human Papillomavirus DNA Tests 1Genetic Testing 1Fulvestrant 1Filgrastim 1Fecal Microbiota Transplantation 1Educational Status 1Drug Therapy 1Diffusion 1Colposcopy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urogenital Neoplasms × Loperamide × Gynecologic × Clear all
NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡